Potassium channels and erectile dysfunction

Vascular Pharmacology

Volumn 38, Issue 1, 2002, Pages 61-71

  Archer, Stephen L ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Gene therapy; High conductance Ca2+ sensitive K+ channels; Hyperpolarization; Impotence; Nitric oxide; Phosphatase inhibitor; Sildenafil; Type 5 phosphodiesterase inhibitor; Vascular biology

Indexed keywords

CALCIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; CYCLIC GMP; GUANYLATE CYCLASE; ION CHANNEL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE INHIBITOR; POTASSIUM CHANNEL; PROTEIN KINASE; SILDENAFIL; ZAPRINAST;

ARTERIAL PRESSURE; ARTICLE; BLOOD; CELL ACTIVATION; CORPUS CAVERNOSUM; CYTOSOL; DIABETES MELLITUS; ENDOTHELIUM CELL; ERECTILE DYSFUNCTION; GENE TRANSFER; HYPERPOLARIZATION; HYPERTENSION; INCIDENCE; ION TRANSPORT; MEMBRANE POTENTIAL; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RISK FACTOR; SEXUAL AROUSAL; SMOKING; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE FIBER MEMBRANE; SMOOTH MUSCLE RELAXATION; SOLUBILITY; SYNTHESIS; VASCULAR DISEASE; VASODILATATION;

AGING; ANIMALS; CYCLIC GMP-DEPENDENT PROTEIN KINASES; GENE THERAPY; HUMANS; IMPOTENCE; MALE; MEMBRANE POTENTIALS; MUSCLE, SMOOTH; NITRIC OXIDE; PENILE ERECTION; PENIS; POTASSIUM CHANNELS;

EID: 0036461562     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(02)00127-1     Document Type: Article

References (60)

1. Archer S., Huang J., Hampl V., Nelson D., Shultz P., Weir E. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 91:1994;7583-7587.
2. Archer S.L., Huang J.M.C., Reeve H.L., Hampl V., Tolarova S., Michelakis E.D., Weir E.K. Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia. Circ. Res. 78:1996;431-442.
3. + channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J. Clin. Invest. 101:1998;2319-2330.
4. Bolotina V.M., Najibi S., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
5. Boolell M., Allen M.J., Ballard S.A., Gepi-Attee S., Muirhead G.J., Naylor A.M., Osterloh I.H., Gingell C. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int. J. Impot. Res. 8:1996;47-52.
6. Boyle P. Epidemiology of erectile dysfunction. Carson C.C.I., Kirby R.S., Goldstein I. Textbook of Erectile Dysfunction. 1999;15-24 ISIS Oxford Press, Oxford, England.
7. Brindley G.S. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. Br. J. Psychiatry. 143:1983;332-337.
8. Browning D.D., Mc Shane M., Marty C., Ye R.D. Functional analysis of type 1a cGMP-dependent protein kinase using green fluorescent fusion proteins. J. Biol. Chem. 276:2001;13039-13048.
9. Burnett A.L., Lowenstein C.J., Bredt D.S., Chang T.S.K., Snyder S.H. Nitric oxide: a physiologic mediator of penile erection. Science. 257:1992;401-403.
10. Burnett A.L., Nelson R.J., Calvin D.C.et al. Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase. Mol. Med. 2:1996;288-296.
11. Campos de Carvalho A.C., Roy C., Moreno A.P., Melman A., Hertzberg E.L., Christ G.J., Spray D.C. Gap junctions formed of connexin 43 are found between smooth muscle cells of human corpus cavernosum. J. Urol. 149:1993;1568-1575.
12. Champion H.C., Bivalacqua T.J., Hyman A.L., Ignarro L.J., Hellstrom W.J., Kadowitz P.J. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc. Natl. Acad. Sci. U. S. A. 96:1999;11648-11652.
13. Christ G.J., Rehman J., Day N., Salkoff L., Valcic M., Melman A., Geliebter J. Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am. J. Physiol. 275:1998;H600-H608.
14. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J. Biol. Chem. 264:1989;1146-1155.
15. Dunsmuir W.D. History of erectile dysfunction. Carson C.C.I., Kirby R.S., Goldstein I. Textbook of Erectile Dysfunction. 1999;3-15 ISIS Oxford Press, Oxford, England.
16. Eckhard C. Untersuchungen uber die erection des peni bein hunde. Beitr. Anat. Physiol. 3:1863;123-150.
17. a) channel in cultured human corporal smooth muscle cells. J. Urol. 153:1995;818-825.
18. Feldman H.A., Johannes C.B., Derby C.A., Kleinman K.P., Mohr B.A., Araujo A.B., McKinlay J.B. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev. Med. 30:2000;328-338.
19. Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am. J. Cardiol. 86:2000;41F-45F.
20. Goldstein I., Lue T., Padma-Nathan H., Rosen R., Steers W., Wicker P. Oral sildenafil in the treatment of erectile dysfunction. N. Engl. J. Med. 338:1998;1397-1404.
21. Gupta S., Salimpour P., Saenz de Tejada I., Daley J., Gholami S., Daller M., Krane R.J., Traish A.M., Goldstein I. A possible mechanism for alteration of human erectile function by digoxin: inhibition of corpus cavernosum sodium/potassium adenosine triphosphatase activity. J. Urol. 159:1998;1529-1536.
22. Hedlund P., Aszodi A., Pfeifer A., Alm P., Hofmann F., Ahmad M., Fassler R., Andersson K.E. Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 97:2000;2349-2354.
23. Holmquist F., Andersson K.E., Hedlund H. Effects of pinacidil on isolated human corpus cavernosum penis. Acta Physiol. Scand. 138:1990;463-469.
24. Holmquist F., Stief C.G., Jonas U., Andersson K.E. Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit. Acta Physiol. Scand. 143:1991;299-304.
25. Hsieh G.C., Kolasa T., Sullivan J.P., Brioni J.D. Dual mechanism of action of nicorandil on rabbit corpus cavernosal smooth muscle tone. Int. J. Impot. Res. 13:2001;240-246.
26. Ignarro L.J., Byrns R.E., Wood K.S. Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. Circ. Res. 60:1987;82-92.
27. Ignarro L.J., Bush P.A., Buga G.M., Wood K.S., Fukuto J.M., Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem. Biophys. Res. Commun. 170:1990;843-850.
28. Jackson W.F. Rp diastereomeric analogs of cAMP inhibit both cAMP- and cGMP-induced dilation of hamster mesenteric small arteries. Pharmacology. 52:1996;226-234.
29. Johannes C.B., Araujo A.B., Feldman H.A., Derby C.A., Kleinman K.P., McKinlay J.B. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J. Urol. 163:2000;460-463.
30. + channels in cultured vascular smooth muscle cells. Circ. Res. 74:1994;471-476.
31. Kuthe A., Wiedenroth A., Magert H.J., Uckert S., Forssmann W.G., Stief C.G., Jonas U. Expression of different phosphodiesterase genes in human cavernous smooth muscle. J. Urol. 165:2001;280-283.
32. Lincoln T.M., Cornwell T.L. Intracellular cyclic GMP receptor proteins. FASEB J. 7:1993;328-338.
33. Malysz J., Gibbons S.J., Miller S.M., Gettman M., Nehra A., Szurszewski J.H., Farrugia G. Potassium outward currents in freshly dissociated rabbit corpus cavernosum myocytes. J. Urol. 166:2001;1167-1177.
34. + channels in coronary smooth muscle during aging. Circ. Res. 88:2001;210-216.
35. 2+-activated potassium channels. Archer S.L., Rusch N.J. Potassium Channels in Cardiovascular Biology. 2001;49-70 Kluwer Academic/Plenum, New York, NY.
36. Melman A., Christ G.J. Integrative erectile biology. The effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction. Urol. Clin. North Am. 28:2001;217-231.
37. Melman A., Rehman J. Pathophysiology of erectile dysfunction. Mol. Urol. 3:1999;87-102.
38. Michelakis E., Tymchak W., Archer S. Sildenafil: from the bench to the bedside. CMAJ. 163:2000;1171-1175.
39. Miller W.H. Physiological effects of cyclic GMP in the vertebrate retinal rod outer segment. Adv. Cyclic Nucleotide Res. 15:1983;495-511.
40. Miller M.A., Morgan R.J., Thompson C.S., Mikhailidis D.P., Jeremy J.Y. Hydrolysis of cyclic guanosine monophosphate and cyclic adenosine monophosphate by the penis and aorta of the diabetic rat. Br. J. Urol. 78:1996;252-256.
41. JAMA, J. Am. Med. Assoc. 270:1993;83-90.
42. Nitahara K.S., Lue T.F. Microscopic anatomy of the penis. Carson C.C.I., Kirby R.S., Goldstein I. Textbook of Erectile Dysfunction. 1999;3141 ISIS Oxford Press, Oxford, England.
43. Post J., Hume J., Archer S., Weir E. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am. J. Physiol. 262:1992;C882-C890.
44. Raeymaekers L., Hofmann F., Casteels R. Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. Biochem. J. 252:1988;269-273.
45. 2+ sensitive to voltage dependent. Am. J. Physiol. 275:1998;L1019-L1025.
46. Robertson B.E., Schubert R., Hescheler J., Nelson M. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am. J. Physiol. 265:1993;C299-C303.
47. Saenz de Tejada I. Molecular mechanisms for the regulation of penile smooth muscle contractility. Int. J. Impot. Res. 12:2000;S34-S38.
48. Shetty S.D., Farah R.N. Anatomy of erectile dysfunction. Carson C.C.I., Kirby R.S., Goldstein I. Textbook of Erectile Dysfunction. 1999;15-24 ISIS Oxford Press, Oxford, England.
49. Stief C.G., Noack T., Andersson K.E. Signal transduction in cavernous smooth muscle. World J. Urol. 15:1997;27-31.
50. 2+ uptake by highly purified sarcolemmal vesicles of vascular smooth muscle. Biochim. Biophys. Acta. 773:1984;83-90.
51. + channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells. Pfluegers Arch. 423:1993;167-172.
52. Trigo-Rocha F., Hsu G.L., Donatucci C.F., Martinez-Pineiro L., Lue T.F., Tanagho E.A. Intracellular mechanism of penile erection in monkeys. Neurourol. Urodyn. 13:1994;71-80.
53. 2+ by sarcoplasmic reticulum in vascular smooth muscle. Circ. Res. 62:1988;961-964.
54. Uckert S., Kuthe A., Stief C.G., Jonas U. Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction. World J. Urol. 19:2001;14-22.
55. van Driel M.F., van de Wiel H.B., Mensink H.J. Some mythologic, religious, and cultural aspects of impotence before the present modern era. Int. J. Impot. Res. 6:1994;163-169.
56. 2+-dependent intracellular signaling mechanisms in brain capillary endothelial cells. J. Neurochem. 62:1994;2269-2274.
57. Virag R. Intracavernous injection of papaverine for erectile failure. Lancet. 2:1982;938.
58. Wanstall J.C., O'Donnell S.R. Age influences responses of rat isolated aorta and pulmonary artery to the calcium channel agonist, Bay K 8664, and to potassium and calcium. J. Cardiovasc. Pharmacol. 13:1989;709-714.
59. Yuan X.-J., Goldman W., Tod M., Rubin L., Blaustein M. Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am. J. Physiol. 264:1993;L116-L123.
60. Zhao Y.J., Wang J., Rubin L.J., Yuan X.J. Inhibition of KV and KCa channels antagonizes NO-induced relaxation in pulmonary artery. Am. J. Physiol. 272:1997;H904-H912.